Novo Nordisk has plummeted back to Earth after a stunning rise driven by Ozempic and Wegovy. Can the storied Danish pharma recover?
A Compounding Problem: How GLP-1s Drove Novo Nordisk’s Rapid Rise and Fall Read More »
After a slow 2024, the biotech shell company Concentra Biosciences is back, offering to buy four biotechs in the past month and seven so far this year.
Tang Capital’s Concentra on Buyout Binge With Plenty of Biotech Fodder Read More »
Nor Healthcare Systems Corp. will set the floor price to buy Prospect’s California hospital portfolio should the sale go to auction. Nor’s director, Michael Sarian, helmed Prospect’s hospital operations more than a decade ago.
Proposed deal would bring former Prospect exec back to distressed hospitals Read More »
New limits to the program could force hospitals to slash capital spending while bracing for millions of newly uninsured patients.
Hospitals prepare for $149B cut to Medicaid state-directed payments Read More »
Hospitals are being advised to stop using the filters after serious injuries were reported related to the problem, the FDA said in a recall notice.
Draeger removes ventilation filters over misleading carbon dioxide readings Read More »
Alastair Thomson, chief data officer at the HHS sub-agency, announced his resignation in opposition to Health Secretary Robert F. Kennedy Jr.’s “stupid” decision to cancel $500 million worth of contracts focused on mRNA technology.
Top ARPA-H Official Departs in Protest of BARDA mRNA Cuts Read More »
Physicians are working harder now than in past years, but they’re getting less for that work, according to new research from Kaufman Hall. The situation could worsen as more Americans lose health insurance.
Physicians are working more but reimbursement isn’t keeping pace, report finds Read More »
PinUp es una página en internet donde se puede apostar de forma rápida y fácil. Aquí hay más de 40 deportes para apuestas deportivas Guatemala. Puedes hacer PinUp Apuesta en fútbol, baloncesto, boxeo y más. El sitio funciona bien en tel&eacu …
PinUp Apuesta: Trucos y consejos para ganar más con tus apuestas Read More »
The company’s stock rose in its first two days on public markets, closing on Monday up almost 58% over the IPO price amid investor enthusiasm.
Sarepta’s troubles had nothing to do with Arrowhead’s assets, and yet both companies have seen their stock prices decline this past month. BioSpace caught up with Arrowhead’s Chris Anzalone to talk about the biotech’s role as an RNAi pipeline savior.
Caught In Sarepta ‘Downdraft,’ Arrowhead Becomes RNAi Knight in Shining Armor Read More »
